Why This Little Known Biotech Is Pharma's New Poster Child for Price Gouging Post author:Sam Post published:December 19, 2017 Post category:BioPharma Another lawmaker is taking on a pharmaceutical company for drug pricing. Source: BioSpace You Might Also Like Curis To Release First Quarter 2017 Financial Results And Hold Conference Call On May 4, 2017 April 30, 2017 Eli Lilly's Taltz Succeeds in Key Phase III Ankylosing Spondylitis Trial February 12, 2018 Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On November 15, 2017
Curis To Release First Quarter 2017 Financial Results And Hold Conference Call On May 4, 2017 April 30, 2017
